爱科赛博公告，因实施2024年年度权益分派，每股现金红利0.16513元，公司调整回购股份价格上限。 调整前回购价格上限为41.67元/股，调整后为41.51元/股，调整于2025年6月25日生效。回购股份数量为 200万股至400万股，预计回购金额为8302万元至1.66亿元。 ...

中国经济网北京6月23日讯 爱科赛博(688719.SH)今日收报39.50元，跌幅3.56%。目前该股处于破 发状态。 爱科赛博于2023年9月28日在上交所科创板上市，发行数量2,062.0000万股，发行价格69.98元/ 股。爱科赛博的保荐机构(主承销商)为长江证券承销保荐有限公司，保荐代表人为李海波、朱伟。 爱科赛博公开发行新股的发行费用合计12,529.36万元(不含增值税金额)，其中保荐及承销费用 10,600.91万元。 参与跟投的保荐人相关子公司长江创新获配股数824,800股，获配股数占发行数量的比例为 4.00%，获配金额57,719,504.00元，限售期24个月。 2024年6月17日，爱科赛博披露的2023年年度权益分派实施公告显示，每股现金红利0.51134元， 每股转增0.4股，股权登记日2024年6月20日，除权(息)日2024年6月21日，新增无限售条件流通股份上 市日2024年6月21日，现金红利发放日2024年6月21日。 上市首日，爱科赛博盘中创下最高价75.39元，为该股上市以来最高价。 爱科赛博新股募集资金总额144,298.76万元，募集资金净额131,769. ...

证券代码：688719 证券简称：爱科赛博 公告编号：2025-044 西安爱科赛博电气股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 是否涉及差异化分红送转：是 ? 每股分配比例 每股现金红利0.16513元 ? 相关日期 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关 法律法规的有关规定，公司回购专用证券账户中的股份不享有股东会表决权、利 润分配、公积金转增股本、认购新股等权利。 （1） 差异化分红方案 公司于 2025 年 4 月 16 日召开第五届董事会第八次会议、第五届监事会第七 次会议，2025 年 5 月 13 日召开 2024 年年度股东大会，审议通过了《关于 2024 年 度利润分配预案的议案》。公司拟以实施权益分派股权登记日的总股本扣减公司回 向全体股东每 10 股派发现金红利 1.66 元（含税）， 购专 ...

Group 1 - The controlled nuclear fusion concept sector experienced a decline of 4.07%, ranking among the top declines in concept sectors, with major stocks like Hezhong Intelligent hitting the limit down [1][2] - Within the controlled nuclear fusion sector, 57 stocks saw net outflows of main funds, totaling 2.774 billion yuan, with Hezhong Intelligent leading the outflow at 314.47 million yuan [2][4] - The top gainers in the sector included Zhongyou Engineering and *ST Xinyan, which rose by 4.12% and 1.81% respectively [1][4] Group 2 - The controlled nuclear fusion sector was among the worst performers today, alongside superconducting concepts and nuclear pollution prevention, which also saw significant declines [2][3] - The main funds saw a net inflow into stocks like Xue Ren Co., Bai Li Electric, and Zhongyou Engineering, with inflows of 39.50 million yuan, 23.15 million yuan, and 18.57 million yuan respectively [2][4] - The stocks with the largest net outflows included Hezhong Intelligent, Xuguang Electronics, and Jingda Co., with outflows of 314.47 million yuan, 247.22 million yuan, and 220.13 million yuan respectively [2][3]

Group 1 - The core point of the news is that Aikesaibo (688719.SH) has experienced a significant decline in stock price, currently trading at 39.59 yuan, reflecting a drop of 10.83% and is in a state of breaking the issue price [1] - Aikesaibo was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 28, 2023, with an issuance of 20.62 million shares at a price of 69.98 yuan per share [1] - The stock reached its highest price of 75.39 yuan on the first day of trading, indicating initial strong market interest [1] Group 2 - The total funds raised by Aikesaibo amounted to 144.29876 million yuan, with a net amount of 131.76940 million yuan, exceeding the original plan by 93.7694 million yuan [1] - The company plans to use the raised funds for several projects, including the industrialization of precision special power supplies and the upgrade of its R&D center [1] - The total issuance costs for the public offering were 12.52936 million yuan, with underwriting fees accounting for 10.60091 million yuan [1] Group 3 - The underwriter's subsidiary, Changjiang Innovation, received 824,800 shares, representing 4.00% of the total issuance, with a total allocation amount of 57,719,504 yuan and a lock-up period of 24 months [2] - Aikesaibo announced a cash dividend of 0.51134 yuan per share and a bonus issue of 0.4 shares per share, with the record date set for June 20, 2024 [2] - The ex-dividend date and the date for the issuance of new shares without restrictions will be June 21, 2024, along with the cash dividend payment on the same day [2]

长江证券承销保荐有限公司 关于西安爱科赛博电气股份有限公司差异化权益分派事项 的核查意见 长江证券承销保荐有限公司（以下简称"长江保荐"或"保荐机构"）作为 西安爱科赛博电气股份有限公司（以下简称"爱科赛博"或"公司"）首次公开 发行股票并在科创板上市的保荐机构，负责爱科赛博的持续督导工作。根据《证 券发行上市保荐业务管理办法》《上海证券交易所上市公司自律监管指引第 7 号 ——回购股份》《上海证券交易所上市公司自律监管指南第 2 号——业务办理》 等有关规定，对爱科赛博差异化权益分派事项进行了审慎核查，发表核查意见如 下： 一、股东大会审议通过的差异化权益分派方案 公司于 2025 年 4 月 16 日召开第五届董事会第八次会议、第五届监事会第七 次会议，2025 年 5 月 13 日召开 2024 年年度股东大会，审议通过了《关于 2024 年度利润分配预案的议案》。 公司 2024 年度共实现归属于上市公司股东净利润为人民币 7,312.42 万元， 其中，母公司实现净利润 8,195.33 万元，母公司期末累计可供分配利润人民币 31,497.25 万元。 公司拟以实施权益分派股权登记日的总股本扣减公 ...

证券代码：688719 证券简称：爱科赛博 公告编号：2025-044 西安爱科赛博电气股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/24 | 2025/6/25 | 2025/6/25 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经西安爱科赛博电气股份有限公司（以下简称"公司"） 2025 年 5 月 13 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关 法律法规的有关规定，公司回购专用证券账户中的股份不享有股东会表决权、利 润分配、公积金转增股本、认购新股等权利 ...

Summary of Key Points Core Viewpoint - On June 16, a total of 12 stocks on the Sci-Tech Innovation Board (STAR Market) experienced block trading, with a cumulative transaction amount of 175 million yuan [1]. Group 1: Trading Overview - There were 22 block trades executed, totaling 5.4936 million shares and an aggregate transaction value of 175 million yuan [1]. - The stock with the highest transaction amount was Qi Anxin, with 2 block trades totaling 880,000 shares and a transaction value of 28.7232 million yuan [1]. - Other notable stocks in terms of transaction value included Jiao Cheng Ultrasound and Siwei Technology, with transaction amounts of 26.9882 million yuan and 20.4719 million yuan, respectively [1]. Group 2: Price and Performance Analysis - The average discount rates for block trades relative to the closing prices were highest for Aotewei, Jingyuan Environmental Protection, and Jiao Cheng Ultrasound, with discount rates of 19.67%, 16.62%, and 11.01% respectively [1]. - The STAR 50 Index fell by 0.21% on the same day, while 399 stocks (67.86%) on the STAR Market saw an increase, with an average increase of 2.07% for stocks involved in block trading [1]. - The top gainers among the stocks with block trades included Jiao Cheng Ultrasound, Aike Saibo, and Delong Laser, with increases of 11.37%, 8.62%, and 6.30% respectively [1]. Group 3: Institutional Participation - Among the block trades, 10 transactions involved institutional buyers or sellers, covering 8 stocks [2]. - The stocks with the highest institutional buying amounts were Siwei Technology, Huitong Co., and Changguang Huaxin, with buying amounts of 20.4719 million yuan, 19.14 million yuan, and 10.524 million yuan respectively [2]. - The stocks with the highest institutional selling amounts included Buke Co., with a selling amount of 9.9384 million yuan [2]. Group 4: Fund Flow Analysis - Five stocks experienced net inflows of main funds, with the highest net inflow recorded for Aike Saibo at 17.0268 million yuan [2]. - The stocks with the highest net outflows included Siwei Technology, Jiao Cheng Ultrasound, and Huitong Co., with net outflows of 14.9344 million yuan, 14.2761 million yuan, and 9.6260 million yuan respectively [2].

Investment Rating - The report suggests a positive investment outlook for the controlled nuclear fusion industry, driven by policy and capital support, with significant potential for growth and commercialization in the coming years [4][30]. Core Insights - Controlled nuclear fusion is viewed as the ultimate energy solution due to its high energy density, abundant fuel supply, and superior safety [4][9]. - The current phase of controlled nuclear fusion is characterized by a dual drive of policy and capital, with numerous projects underway globally, particularly in China and the US, aiming for commercial viability by the 2030s to 2040s [4][30]. - Various technological pathways are emerging, including magnetic confinement (tokamak), inertial confinement (NIF), and magnetic inertial confinement, with significant advancements expected in the next few years [4][30]. Summary by Sections Part 1: What is Controlled Nuclear Fusion? - Controlled nuclear fusion involves the merging of lighter atomic nuclei to form a heavier nucleus, releasing significant energy, primarily using deuterium and tritium as fuel [9][10]. Part 2: Why is Now a New Phase for Controlled Nuclear Fusion? - The industry is experiencing a surge in support from governments worldwide, with China implementing multiple policies to foster development, including financial backing and international collaboration [30][33]. - The number of active fusion companies has increased significantly, with around 50 globally, 80% of which are private enterprises, indicating a robust investment landscape [40][41]. Part 3: Device Architecture Breakdown and Industry Cost Map - The report outlines the cost structure of fusion devices, with initial experimental tokamak investments around 15 billion yuan, and highlights the significant capital required for development [4][30]. Part 4: Competitive Cost of Fusion Power - The report estimates the cost of electricity from fusion devices, with projected costs of 0.31 and 0.27 yuan/kWh for low-temperature superconducting and linear magnetic inertial fusion devices, respectively, indicating competitive pricing compared to traditional energy sources [4][30]. Part 5: Investment Recommendations - The report recommends focusing on key suppliers in the fusion supply chain, including companies like Western Superconducting, Lianchuang Optoelectronics, and Antai Technology, as they are positioned to benefit from the anticipated growth in the fusion sector [4][30].

Core Insights - The total margin financing balance on the STAR Market increased by 335 million yuan, while the margin short selling balance rose by 2.6234 million yuan, indicating a positive trend in investor sentiment [1][2]. Financing Balance Summary - As of June 9, the total margin financing balance reached 153.452 billion yuan, with a financing balance of 152.899 billion yuan and a short selling balance of 5.53 billion yuan [1]. - The stock with the highest financing balance is SMIC, with a latest balance of 7.401 billion yuan, followed by Cambrian and Haiguang Information with balances of 4.305 billion yuan and 3.135 billion yuan respectively [1]. - A total of 342 stocks saw an increase in financing balance, while 241 stocks experienced a decrease [1]. - Notable increases in financing balance include Aikesaibo (54.69%), Zhuoyi Information (38.72%), and Beiqingsong (24.84%), while significant decreases were observed in Zhixiang Jintai (-14.81%), Guobo Electronics (-13.88%), and Aerospace Nanhu (-13.41%) [1]. Short Selling Balance Summary - The stock with the highest short selling balance is Haiguang Information at 19 million yuan, followed by SMIC and Cambrian with balances of 17 million yuan and 14 million yuan respectively [2]. - A total of 165 stocks saw an increase in short selling balance, while 96 stocks experienced a decrease [2]. - Significant increases in short selling balance were noted for Xinghuan Technology (49.33%), Nuotai Biology (49.24%), and Hongwei Technology (45.93%), while the largest decreases were recorded for Aladdin (-100.00%), Zhimingda (-57.54%), and Maixinlin (-47.33%) [2].